Complete Thyroid Panel Beyond TSH And What Each Test Shows

Why TSH Is The Preferred Starting Point

TSH is the single best initial biomarker for primary thyroid disease because of the log-linear relationship between TSH and free T4 (Van Uytfanghe et al., 2023). Small changes in circulating thyroid hormone produce large, measurable shifts in TSH. That sensitivity makes it an early-warning marker. A high TSH suggests the thyroid isn't producing enough hormone (hypothyroidism). A low TSH suggests overproduction (hyperthyroidism).

Most people with an intact pituitary gland and a normal TSH have a functioning thyroid. That's why major guidelines recommend starting with TSH, not a full panel, when thyroid disease is first suspected. The expanded markers come into play when TSH is abnormal, when results conflict with symptoms, or when a specific clinical question requires them.

What Free T4 And Free T3 Add To A TSH Result

Free T4 is the unbound, biologically available form of thyroxine. It reflects what the thyroid gland is producing, filtered for the binding-protein interference that can distort total T4 readings during pregnancy, estrogen therapy, or testosterone use. The ATA states that free T4 "more accurately reflects how the thyroid gland is functioning when checked with a TSH" (ATA). A high TSH paired with a low free T4 points toward primary hypothyroidism. A low TSH with a high free T4 is consistent with hyperthyroidism.

Free T3 is the active thyroid hormone at the tissue level. The thyroid produces mostly T4, which the liver and other tissues convert to T3. A free T3 test is most useful in evaluating hyperthyroidism or T3 toxicosis, where TSH is low and free T4 is normal. In hypothyroidism, the ATA notes that T3 is "the last test to become abnormal" and is rarely helpful for that diagnosis (ATA). A person can have a high TSH and a low free T4 while maintaining a normal T3.

That distinction matters for ordering decisions. Free T4 is almost always worth adding when TSH is abnormal. Free T3 is more targeted and answers a narrower clinical question.

What Do Thyroid Antibodies Tell You?

Thyroid peroxidase (TPO) antibodies and thyroglobulin antibodies screen for autoimmune thyroid disease. TPO antibodies are the primary marker for Hashimoto's thyroiditis, the most common cause of hypothyroidism. Thyroglobulin antibodies support the same clinical finding and are occasionally elevated in Graves' disease.

Antibody testing can indicate autoimmune thyroid activity before TSH becomes abnormal. Positive antibodies don't always progress to overt thyroid disease. But a person with elevated TPO antibodies and a still-normal TSH may be in the early stages of Hashimoto's, which a provider may choose to monitor over time. The ATA notes that while antibodies help confirm the cause of hypothyroidism, serial antibody monitoring doesn't predict disease progression or treatment response (ATA). TSH and free T4 remain the markers for tracking function.

Ordering TPO antibodies makes clinical sense when hypothyroidism is present and the cause is uncertain, when there's a family history of autoimmune thyroid disease, or when a client has other autoimmune conditions. Individual biomarker tests allow clients to add TPO antibodies to any order without purchasing a full panel.

Is Reverse T3 Worth Testing?

Reverse T3 (rT3) is a biologically inactive molecule that the body produces from T4. It shares a structure with T3, but the iodine atoms sit in positions that prevent receptor activation. The ATA states that rT3 testing doesn't help determine whether hypothyroidism is present in healthy, non-hospitalized adults and has no established clinical use (ATA).

Reverse T3 can rise during acute illness, caloric restriction, or physiological stress. Some practitioners order it to assess T4-to-T3 conversion, but no clinical outcome trials support treatment decisions based on reverse T3 levels or T3-to-rT3 ratios (Van Uytfanghe et al., 2023). Assays for rT3 are also poorly standardized across laboratories.

For these reasons, a complete thyroid panel beyond TSH doesn't need to include reverse T3 in most cases. TSH, free T4, free T3, and antibodies answer the questions that evidence-based guidelines support.

How Testosterone Can Change Thyroid Lab Results

Men receiving testosterone therapy may notice shifts in certain thyroid markers. Testosterone (and other androgens) can suppress thyroxine-binding globulin (TBG), the protein that carries T4 and T3 in the blood. Lower TBG means lower total T4 and total T3 readings on a lab report, even when the thyroid itself is working normally.

Free T4 and TSH are less affected by TBG changes, which is why providers monitoring clients on testosterone should rely on free hormone measurements rather than total T4 or total T3. Men already taking levothyroxine who start testosterone may need a dosage review, since the TBG shift can alter how their replacement dose distributes.

This interaction is one reason a TSH test paired with free T4 is the preferred monitoring combination for men on hormone therapy, rather than total thyroid hormone levels alone. Tracking these alongside other markers through a bundled lab panel simplifies the process.

TSH Alone Vs. Expanded Thyroid Panel

The table below compares what each testing approach covers and when it applies. It reflects guideline recommendations from the ATA and the Van Uytfanghe et al. 2023 review.

Neither approach is universally right. The clinical question determines which panel a provider recommends.

When To Order A Complete Thyroid Panel Beyond TSH

Expanded thyroid testing makes sense in specific situations, not as a default screen. Zhang et al. (2024) reported that hypothyroidism affects an estimated 4.7% of the U.S. population based on NHANES data, with rates lower in men than in women (Zhang et al., 2024). Routine ordering of a full panel when TSH is normal and symptoms are absent isn't supported by current guidelines.

Situations where a provider may consider expanded testing include a TSH result that doesn't match clinical symptoms, a family history of autoimmune thyroid disease, suspected hyperthyroidism with a low TSH and a normal free T4, concurrent hormone therapy that could affect binding proteins, and previous thyroid surgery or radioactive iodine treatment. Each situation adds a specific clinical question that TSH alone can't answer.

Clients who want to test individual thyroid markers can build a custom panel or choose from health panels that include thyroid markers alongside metabolic and hormone biomarkers. A ferritin test or iron panel may also be relevant, since iron deficiency can produce symptoms that overlap with thyroid dysfunction, including fatigue.

Biotin supplements can interfere with several thyroid immunoassays. The ATA recommends stopping biotin at least 2 days before a thyroid blood draw (ATA).

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

What does a complete thyroid panel beyond TSH include? 

A complete thyroid panel beyond TSH typically adds free T4, free T3, TPO antibodies, and thyroglobulin antibodies to the standard TSH draw. Each marker measures a different part of thyroid regulation. Free T4 reflects gland output, free T3 reflects active hormone at the tissue level, and antibodies screen for autoimmune thyroid disease.

Is TSH enough to check thyroid function? 

TSH is the preferred initial test for most people, according to the American Thyroid Association. It catches primary hypothyroidism and hyperthyroidism with high sensitivity. Additional markers are added when TSH is abnormal, when results conflict with symptoms, or when a provider suspects autoimmune disease or conversion problems.

Should I test reverse T3? 

The American Thyroid Association states that reverse T3 measurement does not help determine whether hypothyroidism is present in healthy, non-hospitalized people. No clinical outcome trials support treatment changes based on reverse T3 levels. Most evidence-based thyroid panels exclude it.

Can testosterone therapy affect thyroid test results? 

Testosterone can lower thyroxine-binding globulin (TBG), which reduces total T4 and total T3 readings on lab work. Free hormone levels and TSH typically remain stable in men with normal thyroid function. Providers monitoring clients on testosterone should rely on free T4 and TSH rather than total hormone measurements.

How common is thyroid dysfunction in men? 

Thyroid dysfunction is less common in men than women. Zhang et al. (2024) reported overall hypothyroidism prevalence at 4.7% in the U.S. population using NHANES data, with lower rates in men. Antibody positivity is also less frequent in men (Hollowell et al., 2002).

When should I order thyroid antibodies? 

A provider may recommend TPO antibody testing when hypothyroidism is present and the cause is unclear, when there's a family history of autoimmune thyroid disease, or when assessing future risk. Positive antibodies with a normal TSH may indicate early autoimmune thyroid activity, though they don't always progress to overt disease.

References

• Thyroid. 2023;33(9):1013-1028

• J Clin Endocrinol Metab. 2024;109(2):e657-e666

• J Clin Endocrinol Metab. 2002;87(2):489-499